October 04, 2018 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: Implanet (Paris:ALIMP) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729, eligible for PEA-PME equity savings plans; OTCQX: IMPZY), a medical technology company specializing in vertebral and knee surgery implants, announces the completion of its first surgery in the United Kingdom via Implanet UK, at the Royal Orthopaedic Hospital of Birmingham, following the […]